Structural and functional changes in HDL with low grade and chronic inflammation

International Journal of Cardiology

Volumn 188, Issue 1, 2015, Pages 111-116

  O'Neill, Francis ^a   Riwanto, Meliana ^b   Charakida, Marietta ^a   Colin, Sophie ^c   Manz, Jasmin ^b   McLoughlin, Eve ^a   Khan, Tauseef ^a   Klein, Nigel ^d   Kay, Christopher W M ^a   Patel, Kalpesh ^a   Chinetti, Giulia ^c   Staels, Bart ^c   D'Aiuto, Francesco ^a   Landmesser, Ulf ^b   Deanfield, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIV LILLE   (France)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Atherosclerosis; High density lipoprotein; Inflammation

Indexed keywords

ARYLDIALKYLPHOSPHATASE; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; NITRIC OXIDE; PROTEOME; SUPEROXIDE; VASCULAR CELL ADHESION MOLECULE 1; AUTACOID;

ADULT; ARTICLE; BIOAVAILABILITY; CELL PROTECTION; CHOLESTEROL TRANSPORT; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; LOW GRADE INFLAMMATION; MIDDLE AGED; PERIODONTAL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; BLOOD; CASE CONTROL STUDY; CHRONIC DISEASE; COMPARATIVE STUDY; FEMALE; FOLLOW UP; LONGITUDINAL STUDY; MALE; METABOLISM; PATHOPHYSIOLOGY; PERIODONTITIS; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

ADULT; ARYLDIALKYLPHOSPHATASE; CASE-CONTROL STUDIES; CHRONIC DISEASE; ENDOTHELIAL CELLS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPROTEINS, HDL; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NITRIC OXIDE; PERIODONTITIS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84929218859     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.058     Document Type: Article

References (30)

1. D.J. Gordon, J.L. Probstfield, R.J. Garrison, J.D. Neaton, W.P. Castelli, J.D. Knoke, D.R. Jacobs Jr., S. Bangdiwala, H.A. Tyroler, High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies, Circulation 79 (1) (Jan. 1989) 8-15.
2. A.R. Sharrett, C.M. Ballantyne, S.A. Coady, G. Heiss, P.D. Sorlie, D. Catellier, W. Patsch, Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, andHDL density subfractions: theAtherosclerosis Risk in Communities (ARIC) Study, Circulation 104 (10) (Sept. 2001) 1108-1113.
3. C. Mineo, P.W. Shaul, Novel biological functions of high-density lipoprotein cholesterol, Circ. Res. 111 (8) (Sept. 2012) 1079-1090.
4. C. Mineo, I.S. Yuhanna, M.J. Quon, P.W. Shaul, High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases, J. Biol. Chem. 278 (11) (Mar. 2003) 9142-9149.
5. C. Besler, T.F. Luscher, U. Landmesser, Molecular mechanisms of vascular effects of high-density lipoprotein: alterations in cardiovascular disease, EMBO Mol. Med. 4 (4) (Apr. 2012) 251-268.
6. S.A. Sorrentino, C. Besler, L. Rohrer, M. Meyer, K. Heinrich, F.H. Bahlmann, M. Mueller, T. Horvath, C. Doerries, M. Heinemann, S. Flemmer, A. Markowski, C. Manes, M.J. Bahr, H. Haller, E.A. von, H. Drexler, U. Landmesser, Endothelialvasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy, Circulation 121 (1) (Jan. 2010) 110-122.
7. G.D. Norata, A. Pirillo, E. Ammirati, A.L. Catapano, Emerging role of high density lipoproteins as a player in the immune system, Atherosclerosis 220 (1) (Jan. 2012) 11-21.
8. L. Yvan-Charvet, T. Pagler, E.L. Gautier, S. Avagyan, R.L. Siry, S. Han, C.L. Welch, N. Wang, G.J. Randolph, H.W. Snoeck, A.R. Tall, ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation, Science 328 (5986) (June 2010) 1689-1693.
9. M. Charakida, C. Besler, J.R. Batuca, S. Sangle, S. Marques, M. Sousa, G. Wang, D. Tousoulis, A.J. Delgado, S.P. Loukogeorgakis, C. Mackworth-Young, D. D'Cruz, T. Luscher, U. Landmesser, J.E. Deanfield, Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome, JAMA 302 (11) (Sept. 2009) 1210-1217.
10. T. Vaisar, S. Pennathur, P.S. Green, S.A. Gharib, A.N. Hoofnagle, M.C. Cheung, J. Byun, S. Vuletic, S. Kassim, P. Singh, H. Chea, R.H. Knopp, J. Brunzell, R. Geary, A. Chait, X.Q. Zhao, K. Elkon, S. Marcovina, P. Ridker, J.F. Oram, J.W. Heinecke, Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL, J. Clin. Invest. 117 (3) (Mar. 2007) 746-756.
11. C. Charles-Schoeman, J. Watanabe, Y.Y. Lee, D.E. Furst, S. Amjadi, D. Elashoff, G. Park, M. McMahon, H.E. Paulus A.M. Fogelman, S.T. Reddy, Abnormalfunction of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis, Arthritis Rheum. 60 (10) (Oct. 2009) 2870-2879.
12. M.S. Tonetti, F. D'Aiuto, L. Nibali, A. Donald, C. Storry, M. Parkar, J. Suvan, A.D. Hingorani, P. Vallance, J. Deanfield, Treatment of periodontitis and endothelial function, N. Engl. J. Med. 356 (9) (Mar. 2007) 911-920.
13. F. D'Aiuto, L. Nibali, V. Mohamed-Ali, P. Vallance, M.S. Tonetti, Periodontal therapy: a novel non-drug-induced experimental model to study human inflammation, J. Periodontal Res. 39 (5) (Oct. 2004) 294-299.
14. H. Tong, H.R. Knapp, M. VanRollins, A low temperature flotation method to rapidly isolate lipoproteins from plasma, J. Lipid Res. 39 (8) (Aug. 1998) 1696-1704.
15. A.L. Kleschyov, H. Mollnau, M. Oelze, T. Meinertz, Y. Huang, D.G. Harrison, T. Munzel, Spin trapping of vascular nitric oxide using colloid Fe(II)-diethyldithiocarbamate, Biochem. Biophys. Res. Commun. 275 (2) (Aug. 2000) 672-677.
16. A.V. Khera, M. Cuchel, M. Llera-Moya, A. Rodrigues, M.F. Burke, K. Jafri, B.C. French, J.A. Phillips, M.L. Mucksavage, R.L. Wilensky, E.R. Mohler, G.H. Rothblat, D.J. Rader, Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis, N. Engl. J. Med. 364 (2) (Jan. 2011) 127-135.
17. T. Bhattacharyya, S.J. Nicholls, E.J. Topol, R. Zhang, X. Yang, D. Schmitt, X. Fu, M. Shao, D.M. Brennan, S.G. Ellis, M.L. Brennan, H. Allayee, A.J. Lusis, S.L. Hazen, Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk, JAMA 299 (11) (Mar. 2008) 1265-1276.
18. P.M. Ridker, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto Jr., J.J. Kastelein, W. Koenig, P. Libby, A.J. Lorenzatti, J.G. MacFadyen, B.G. Nordestgaard, J. Shepherd, J.T. Willerson, R.J. Glynn, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N. Engl. J. Med. 359 (21) (Nov. 2008) 2195-2207.
19. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S), Lancet 344 (8934) (Nov. 1994) 1383-1389.
20. J.P. Despres, I. Lemieux, G.R. Dagenais, B. Cantin, B. Lamarche, HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study, Atherosclerosis 153 (2) (Dec. 2000) 263-272.
21. W.E. Boden, J.L. Probstfield, T. Anderson, B.R. Chaitman, P. Desvignes-Nickens, K. Koprowicz, R. McBride, K. Teo, W. Weintraub, Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy, N. Engl. J. Med. 365 (24) (Dec. 2011) 2255-2267.
22. G.G. Schwartz, A.G. Olsson, M. Abt, C.M. Ballantyne, P.J. Barter, J. Brumm, B.R. Chaitman, I.M. Holme, D. Kallend, L.A. Leiter, E. Leitersdorf, J.J. McMurray, H. Mundl, S.J. Nicholls, P.K. Shah, J.C. Tardif, R.S. Wright, Effects of dalcetrapib in patients with a recent acute coronary syndrome, N. Engl. J. Med. 367 (22) (Nov. 2012) 2089-2099.
23. M.G. Sorci-Thomas, M.J. Thomas, High density lipoprotein biogenesis, cholesterol efflux, and immune cell function, Arterioscler. Thromb. Vasc. Biol. 32 (11) (Nov. 2012) 2561-2565.
24. M. Navab, S.T. Reddy, B.J. Van Lenten, A.M. Fogelman, HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms, Nat. Rev. Cardiol. 8 (4) (Apr. 2011) 222-232.
25. T. Speer, L. Rohrer, P. Blyszczuk, R. Shroff, K. Kuschnerus, N. Krankel, G. Kania, S. Zewinger, A. Akhmedov, Y. Shi, T. Martin, D. Perisa, S. Winnik, M.F. Muller, U. Sester, G. Wernicke, A. Jung, U. Gutteck, U. Eriksson, J. Geisel, J. Deanfield, E.A. von, T.F. Luscher, D. Fliser, F.H. Bahlmann, U. Landmesser, Abnormal high-density lipoprotein induces endothelial dysfunction via activation of toll-like receptor-2, Immunity 38 (4) (Apr. 2013) 754-768.
26. C. Besler, K. Heinrich, L. Rohrer, C. Doerries, M. Riwanto, D.M. Shih, A. Chroni, K. Yonekawa, S. Stein, N. Schaefer, M. Mueller, A. Akhmedov, G. Daniil, C. Manes, C. Templin, C. Wyss, W. Maier, F.C. Tanner, C.M. Matter, R. Corti, C. Furlong, A.J. Lusis, E.A. von, A.M. Fogelman, T.F. Luscher, U. Landmesser, Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease, J. Clin. Investig. 121 (7) (July 2011) 2693-2708.
27. T. Vos, A.D. Flaxman, M. Naghavi, R. Lozano, C. Michaud, M. Ezzati, K. Shibuya, J.A. Salomon, S. Abdalla, V. Aboyans, J. Abraham, I. Ackerman, R. Aggarwal, S.Y. Ahn, M.K. Ali, M. Alvarado, H.R. Anderson, L.M. Anderson, K.G. Andrews, C. Atkinson, L.M. Baddour, A.N. Bahalim, S. Barker-Collo, L.H. Barrero, D.H. Bartels, M.G. Basanez, A. Baxter, M.L. Bell, E.J. Benjamin, D. Bennett, E. Bernabe, K. Bhalla, B. Bhandari, B. Bikbov, A.A. Bin, G. Birbeck, J.A. Black, H. Blencowe, J.D. Blore, F. Blyth, I. Bolliger, A. Bonaventure, S. Boufous, R. Bourne, M. Boussinesq, T. Braithwaite, C. Brayne, L. Bridgett, S. Brooker, P. Brooks, T.S. Brugha, C. Bryan-Hancock, C. Bucello, R. Buchbinder, G. Buckle, C.M. Budke, M. Burch, P. Burney, R. Burstein, B. Calabria, B. Campbell, C.E. Canter, H. Carabin, J. Carapetis, L. Carmona, C. Cella, F. Charlson, H. Chen, A.T. Cheng, D. Chou, S.S. Chugh, L.E. Coffeng, S.D. Colan, S. Colquhoun, K.E. Colson, J. Condon, M.D. Connor, L.T. Cooper, M. Corriere, M. Cortinovis, K.C. de Vaccaro, W. Couser, B.C. Cowie, M.H. Criqui, M. Cross, K.C. Dabhadkar, M. Dahiya, N. Dahodwala, J. Damsere-Derry, G. Danaei, A. Davis, L.D. De, L. Degenhardt, R. Dellavalle, A. Delossantos, J. Denenberg, S. Derrett, D.C. Des Jarlais, S.D. Dharmaratne, M. Dherani, C. Diaz-Torne, H. Dolk, E.R. Dorsey, T. Driscoll, H. Duber, B. Ebel, K. Edmond, A. Elbaz, S.E. Ali, H. Erskine, P.J. Erwin, P. Espindola, S.E. Ewoigbokhan, F. Farzadfar, V. Feigin, D.T. Felson, A. Ferrari, C.P. Ferri, E.M. Fevre, M.M. Finucane, S. Flaxman, L. Flood, K. Foreman, M.H. Forouzanfar, F.G. Fowkes, R. Franklin, M. Fransen, M.K. Freeman, B.J. Gabbe, S.E. Gabriel, E. Gakidou, H.A. Ganatra, B. Garcia, F. Gaspari, R.F. Gillum, G. Gmel, R. Gosselin, R. Grainger, J. Groeger, F. Guillemin, D. Gunnell, R. Gupta, J. Haagsma, H. Hagan, Y.A. Halasa, W. Hall, D. Haring, J.M. Haro, J.E. Harrison, R. Havmoeller, R.J. Hay, H. Higashi, C. Hill, B. Hoen, H. Hoffman, P.J. Hotez, D. Hoy, J.J. Huang, S.E. Ibeanusi, K.H. Jacobsen, S.L. James, D. Jarvis, R. Jasrasaria, S. Jayaraman, N. Johns, J.B. Jonas, G. Karthikeyan, N. Kassebaum, N. Kawakami, A. Keren, J.P. Khoo, C.H. King, L.M. Knowlton, O. Kobusingye, A. Koranteng, R. Krishnamurthi, R. Lalloo, L.L. Laslett, T. Lathlean, J.L. Leasher, Y.Y. Lee, J. Leigh, S.S. Lim, E. Limb, J.K. Lin, M. Lipnick, S.E. Lipshultz, W. Liu, M. Loane, S.L. Ohno, R. Lyons, J. Ma, J. Mabweijano, M.F. MacIntyre, R. Malekzadeh, L. Mallinger, S. Manivannan, W. Marcenes, L. March, D.J. Margolis, G.B. Marks, R. Marks, A. Matsumori, R. Matzopoulos, B.M. Mayosi, J.H. McAnulty, M.M. McDermott, N. McGill, J. McGrath, M.E. Medina-Mora, M. Meltzer, G.A. Mensah, T.R. Merriman, A.C. Meyer, V. Miglioli, M. Miller, T.R. Miller, P.B. Mitchell, A.O. Mocumbi, T.E. Moffitt, A.A. Mokdad, L. Monasta, M. Montico, M. Moradi-Lakeh, A. Moran, L. Morawska, R. Mori, M.E. Murdoch, M.K. Mwaniki, K. Naidoo, M.N. Nair, L. Naldi, K.M. Narayan, P.K. Nelson, R.G. Nelson, M.C. Nevitt, C.R. Newton, S. Nolte, P. Norman, R. Norman, M. O'Donnell, S. O'Hanlon, C. Olives, S.B. Omer, K. Ortblad, R. Osborne, D. Ozgediz, A. Page, B. Pahari, J.D. Pandian, A.P. Rivero, S.B. Patten, N. Pearce, R.P. Padilla, F. Perez-Ruiz, Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet 380 (9859) (Dec.2012) 2163-2196.
28. M. Navab, J.A. Berliner, G. Subbanagounder, S. Hama, A.J. Lusis, L.W. Castellani, S. Reddy, D. Shih, W. Shi, A.D. Watson, B.J. Van Lenten, D. Vora, A.M. Fogelman, HDL and the inflammatory response induced by LDL-derived oxidized phospholipids, Arterioscler. Thromb. Vasc. Biol. 21 (4) (Apr. 2001) 481-488.
29. R.S. Birjmohun, S.I. van Leuven, J.H. Levels, V. van, J.A. Kuivenhoven, J.C. Meijers, M. Levi, J.J. Kastelein, T. van der Poll, E.S. Stroes, High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans, Arterioscler. Thromb. Vasc. Biol. 27 (5) (May 2007) 1153-1158.
30. P.J. Barter, M. Caulfield, M. Eriksson, S.M. Grundy, J.J. Kastelein, M. Komajda, J. Lopez-Sendon, L. Mosca, J.C. Tardif, D.D. Waters, C.L. Shear, J.H. Revkin, K.A. Buhr, M.R. Fisher, A.R. Tall, B. Brewer, Effects of torcetrapib in patients at high risk for coronary events, N. Engl. J. Med. 357 (21) (Nov. 2007) 2109-2122.